148 related articles for article (PubMed ID: 12387678)
1. Translation elongation-3-like factors: are they rational antifungal targets?
Sturtevant J
Expert Opin Ther Targets; 2002 Oct; 6(5):545-53. PubMed ID: 12387678
[TBL] [Abstract][Full Text] [Related]
2. Elongation factor 2 as a novel target for selective inhibition of fungal protein synthesis.
Justice MC; Hsu MJ; Tse B; Ku T; Balkovec J; Schmatz D; Nielsen J
J Biol Chem; 1998 Feb; 273(6):3148-51. PubMed ID: 9452424
[TBL] [Abstract][Full Text] [Related]
3. Echinocandin resistance in human pathogenic fungi.
Munro CA
Expert Rev Anti Infect Ther; 2012 Feb; 10(2):115-6. PubMed ID: 22339184
[No Abstract] [Full Text] [Related]
4. Sordarins: A new class of antifungals with selective inhibition of the protein synthesis elongation cycle in yeasts.
Domínguez JM; Kelly VA; Kinsman OS; Marriott MS; Gómez de las Heras F; Martín JJ
Antimicrob Agents Chemother; 1998 Sep; 42(9):2274-8. PubMed ID: 9736548
[TBL] [Abstract][Full Text] [Related]
5. Species-specific inhibition of fungal protein synthesis by sordarin: identification of a sordarin-specificity region in eukaryotic elongation factor 2.
Shastry M; Nielsen J; Ku T; Hsu MJ; Liberator P; Anderson J; Schmatz D; Justice MC
Microbiology (Reading); 2001 Feb; 147(Pt 2):383-390. PubMed ID: 11158355
[TBL] [Abstract][Full Text] [Related]
6. Translation elongation factor-3 (EF-3): an evolving eukaryotic ribosomal protein?
Belfield GP; Ross-Smith NJ; Tuite MF
J Mol Evol; 1995 Sep; 41(3):376-87. PubMed ID: 7563124
[TBL] [Abstract][Full Text] [Related]
7. Antifungals targeted to protein modification: focus on protein N-myristoyltransferase.
Georgopapadakou NH
Expert Opin Investig Drugs; 2002 Aug; 11(8):1117-25. PubMed ID: 12150705
[TBL] [Abstract][Full Text] [Related]
8. Antifungal agents: mode of action in yeast cells.
Carrillo-Muñoz AJ; Giusiano G; Ezkurra PA; Quindós G
Rev Esp Quimioter; 2006 Jun; 19(2):130-9. PubMed ID: 16964330
[TBL] [Abstract][Full Text] [Related]
9. Translation elongation factor 3: a fungus-specific translation factor?
Belfield GP; Tuite MF
Mol Microbiol; 1993 Aug; 9(3):411-8. PubMed ID: 8412690
[TBL] [Abstract][Full Text] [Related]
10. Antifungals: Mechanism of Action and Drug Resistance.
Prasad R; Shah AH; Rawal MK
Adv Exp Med Biol; 2016; 892():327-349. PubMed ID: 26721281
[TBL] [Abstract][Full Text] [Related]
11. Potential targets for the development of new antifungal drugs.
Su H; Han L; Huang X
J Antibiot (Tokyo); 2018 Nov; 71(12):978-991. PubMed ID: 30242283
[TBL] [Abstract][Full Text] [Related]
12. Antifungal drug resistance of pathogenic fungi.
Kontoyiannis DP; Lewis RE
Lancet; 2002 Mar; 359(9312):1135-44. PubMed ID: 11943280
[TBL] [Abstract][Full Text] [Related]
13. Drug resistance: the fight against fungi.
Goffeau A
Nature; 2008 Apr; 452(7187):541-2. PubMed ID: 18385723
[No Abstract] [Full Text] [Related]
14. Resistance in human pathogenic yeasts and filamentous fungi: prevalence, underlying molecular mechanisms and link to the use of antifungals in humans and the environment.
Jensen RH
Dan Med J; 2016 Oct; 63(10):. PubMed ID: 27697142
[TBL] [Abstract][Full Text] [Related]
15. Genomics, molecular targets and the discovery of antifungal drugs.
Odds FC
Rev Iberoam Micol; 2005 Dec; 22(4):229-37. PubMed ID: 16499416
[TBL] [Abstract][Full Text] [Related]
16. Validation of Cdc68p as a novel antifungal target.
Buurman ET; Jiang W; McCoy M; Averett DR; Thompson CM; Wobbe CR
Arch Microbiol; 2002 Dec; 178(6):428-36. PubMed ID: 12420162
[TBL] [Abstract][Full Text] [Related]
17. Synergy of the antibiotic colistin with echinocandin antifungals in Candida species.
Zeidler U; Bougnoux ME; Lupan A; Helynck O; Doyen A; Garcia Z; Sertour N; Clavaud C; Munier-Lehmann H; Saveanu C; d'Enfert C
J Antimicrob Chemother; 2013 Jun; 68(6):1285-96. PubMed ID: 23378416
[TBL] [Abstract][Full Text] [Related]
18. Generating anchors only to lose them: The unusual story of glycosylphosphatidylinositol anchor biosynthesis and remodeling in yeast and fungi.
Komath SS; Singh SL; Pratyusha VA; Sah SK
IUBMB Life; 2018 May; 70(5):355-383. PubMed ID: 29679465
[TBL] [Abstract][Full Text] [Related]
19. New Mechanisms of Flucytosine Resistance in C. glabrata Unveiled by a Chemogenomics Analysis in S. cerevisiae.
Costa C; Ponte A; Pais P; Santos R; Cavalheiro M; Yaguchi T; Chibana H; Teixeira MC
PLoS One; 2015; 10(8):e0135110. PubMed ID: 26267134
[TBL] [Abstract][Full Text] [Related]
20. Systemic Antifungal Agents: Current Status and Projected Future Developments.
Seyedmousavi S; Rafati H; Ilkit M; Tolooe A; Hedayati MT; Verweij P
Methods Mol Biol; 2017; 1508():107-139. PubMed ID: 27837500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
